Tag
bioAffinity Technologies
- bioAffinity Technologies reports more than 1,620 CyPath Lung tests
- bioAffinity Technologies jumps 63% on Hong Kong lung cancer screening patent
- bioAffinity jumps 45% from lung cancer phlegm test expansion
- Young Muay Thai fighter's lung cancer death raises screening eligibility concerns
- AI‑powered light scan could speed up targeted lung cancer treatments
- PrognomiQ shares promising early results from novel lung cancer blood test
- Guardant Health and Zydus to launch 'Shield' multi-cancer test in India
- Ohio's 'Breath of Hope' Gala raises money for lung cancer research
- American lung cancer survivor advocates for low‑dose CT scans in new book
- bioAffinity Technologies soars Monday as non‑invasive lung cancer tech gains traction
- bioAffinity launches 2,000‑patient study for noninvasive lung cancer test
- BioMark Diagnostics receives Innovation Award for lung cancer screening project
- Boosting U.S. lung cancer screening uptake could save 62,000 lives in 5 years
- Guardant Health backs lung cancer screening advocacy campaign
- bioAffinity Technologies obtains Canadian patent for lung cancer spit test
- bioAffinity Technologies secures Australian patent for 'CyPath Lung' spit test
- bioAffinity Technologies makes phlegm lung cancer test widely available to Veterans